Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist
After dropping so-so results on its dual GLP-1/GLP-2, fierce competition in obesity has persuaded Zealand to aim its development engine elsewhere.
Fraiser Kansteiner
Nov 13, 2025 9:52am
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor
Nov 10, 2025 6:26am
Roche signs $2B pact to pilot Manifold's shuttles to the brain
Nov 3, 2025 8:45am
Roche pens $1B deal for respiratory bispecific from China
Oct 30, 2025 5:04am
Genentech lets 118 staffers go in another HQ layoff round
Oct 29, 2025 4:55pm
Roche's Flatiron Health debuts 6 new blood cancer data sets
Oct 29, 2025 9:00am